Applied BioCode (6598) — Capital Reinvestment Ratio
Applied BioCode (6598) has a Capital Reinvestment Ratio of 1.89x as of September 2022, meaning it reinvests 2% of its operating cash flow (NT$6.35 Million) in capital expenditures (NT$12.00 Million). Check Applied BioCode (6598) tangible net worth to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Applied BioCode Capital Reinvestment Ratio (2022–2022)
This chart tracks Applied BioCode's Capital Reinvestment Ratio across 1 annual periods. For the full cash flow conversion analysis, see 6598 cash flow conversion.
Annual Capital Reinvestment Ratio for Applied BioCode (2022–2022)
Year-by-year Capital Reinvestment Ratio for Applied BioCode from 2022 to 2022. See free cash flow generation of Applied BioCode to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (TWD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.15x | NT$145.87 Million | NT$22.14 Million | — |